Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine, Bharat Biotech did not try to supress the side effects of vaccine by giving paracetamol to the volunteers

The European Medicines Agency's  Deputy Executive Director Noel Wathion has said AstraZeneca and the University of Oxford have not filed an application for approval until now

Post an expert meeting on Monday, the EMA declared their recommendation that the shot be licensed for use in people over the age of 16 years, barring some exceptions

The shots for Sputnik V are available for free for those in medical and educational facilities, whether owned by the state or privately. Social and municipal workers, retail and service workers, and those in the arts can also get the shots at no cost

The EMA, which assesses medicines and vaccines for the European Union, said earlier this month that it had been targeted in a cyberattack

Pharmaceutical giant Pfizer Inc has revealed that some of the data it had submitted to Europe's top drug regulator had been accessed by hackers.

UN Secretary-General Antonio Guterres  has said that he intends to take the COVID-19 vaccine when it becomes available and he will do so publicly, asserting that vaccination for him is a moral obligation

The Amsterdam-based European Medicines Agency, which is considering requests for conditional marketing authorisation for several coronavirus vaccines to be used in the 27-nation European Union, said earlier on Wednesday that it had been the target of a cyberattack

Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India

On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout

Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data

The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU

Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon

India Stock Market Highlights Today: HDFC twins, Reliance Industries were among the top losers and Tata Steel, Titan and Asian Paints were among the top gainers

Dalal Street today: UltraTech Cement followed by Infosys, Sun Pharma, Bajaj Auto PowerGrid, ICICI Bank and IndusInd Bank were among the top gainers in the Sensex pack. On the other hand, ONGC, M&M, Nestle India, Axis Bank and HDFC were among the laggards

Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day

Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe

British-Swedish pharma giant AstraZeneca Plc is hoping for the new test to substantiate the 90 per cent efficacy rate the inoculation demonstrated in a portion of an ongoing trial

The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States

Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites